127 related articles for article (PubMed ID: 24065222)
1. Fibrosis in heart failure subtypes.
Toprak G; Yüksel H; Demirpençe Ö; Islamoglu Y; Evliyaoglu O; Mete N
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2302-9. PubMed ID: 24065222
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
[TBL] [Abstract][Full Text] [Related]
3. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
[TBL] [Abstract][Full Text] [Related]
4. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
5. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
[TBL] [Abstract][Full Text] [Related]
6. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
Kaye DM; Khammy O; Mariani J; Maeder MT
Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
8. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
Tziakas DN; Chalikias GK; Papaioakeim M; Hatzinikolaou EI; Stakos DA; Tentes IK; Papanas N; Kortsaris A; Maltezos E; Hatseras DI
Am J Cardiol; 2005 Nov; 96(10):1449-51. PubMed ID: 16275197
[TBL] [Abstract][Full Text] [Related]
9. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.
Batlle M; Pérez-Villa F; García-Pras E; Lázaro A; Orús J; Roqué M; Roig E
Transplant Proc; 2007 Sep; 39(7):2344-6. PubMed ID: 17889183
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis.
Çelik Ö; Şahin AA; Sarıkaya S; Uygur B
Anatol J Cardiol; 2020 Nov; 24(5):303-308. PubMed ID: 33122477
[TBL] [Abstract][Full Text] [Related]
12. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
14. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.
Milting H; Ellinghaus P; Seewald M; Cakar H; Bohms B; Kassner A; Körfer R; Klein M; Krahn T; Kruska L; El Banayosy A; Kramer F
J Heart Lung Transplant; 2008 Jun; 27(6):589-96. PubMed ID: 18503956
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J
J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093
[TBL] [Abstract][Full Text] [Related]
16. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
Ohtsuka T; Nishimura K; Kurata A; Ogimoto A; Okayama H; Higaki J
J Card Fail; 2007 Nov; 13(9):752-8. PubMed ID: 17996824
[TBL] [Abstract][Full Text] [Related]
17. Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure.
Täger T; Wiebalck C; Fröhlich H; Corletto A; Katus HA; Frankenstein L
Clin Res Cardiol; 2017 Dec; 106(12):974-985. PubMed ID: 28779229
[TBL] [Abstract][Full Text] [Related]
18. Heart rate variability in heart failure.
Musialik-Łydka A; Sredniawa B; Pasyk S
Kardiol Pol; 2003 Jan; 58(1):10-6. PubMed ID: 14502297
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood levels of matrix metalloproteinases in patients referred for percutaneous balloon mitral valve commissurotomy.
Garr RJ; Krasuski RA; Eckart RE; Wang A; Pierce C; Kisslo KB; Harrison JK; Bashore TM
J Heart Valve Dis; 2006 May; 15(3):369-74. PubMed ID: 16784074
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
